Flow diversion is a novel therapeutic approach for the treatment of anatomically challenging intracranial aneurysms, and this approach has gained traction over the years. Flow diversion aneurysm is an endovascular technique in which the device is placed in the parent blood vessel to divert blood flow away from the aneurysm itself. The technological advancements along with the clinical results indicate that flow diversion aneurysm is safe as well as effective in the treatment of ruptured aneurysms, posterior circulation aneurysms, and distal anterior circulation aneurysms.

Increase in incidence of brain aneurysm and rise in demand for minimally invasive endovascular surgeries drive the market. However, risk of post-operative complications and stringent regulations regarding the approval of the devices restrain the market growth. Moreover, technological advancements in the flow diversion aneurysm treatment offer lucrative opportunities for the expansion of the market.

The market is segmented on the basis of region. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key players that operate in the market are Balt Extrusion, Medtronic Plc, Stryker Corporation, Acandis GmbH, InspireMD, phenox GmbH, and MicroVention, Inc.

Key Benefits

• The study provides an in-depth analysis of the global flow diversion aneurysm market with current trends and future estimations to elucidate imminent investment pockets.
• It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
• Key players are profiled and their strategies thoroughly analyzed, which predicts the competitive outlook of the market.

 Key Market Segments

• By Product
  • Intrasaccular flow disruption devices
  • FDS
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

 
Key Market Players

• Boston Scientific Corp.
• Stryker Corporation
• InspireMD
• Balt Extrusion
• Medtronic Plc
• Cook Group Inc.
• Phenox GmbH
• Acandis GmbH
• MicroVention, Inc.
• Cardinal Health Inc.

• CHAPTER 1: INTRODUCTION

  • 1.1. Report Description

  • 1.2. Key Market Segments

  • 1.3. Key Benefits

  • 1.4. Research Methodology

    • 1.4.1. Primary Research

    • 1.4.2. Secondary Research

    • 1.4.3. Analyst Tools and Models

• CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

• CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope

  • 3.2. Key Findings

    • 3.2.1. Top Investment Pockets

    • 3.2.2. Top Winning Strategies

  • 3.3. Porter's Five Forces Analysis

    • 3.3.1. Bargaining Power of Suppliers

    • 3.3.2. Threat of New Entrants

    • 3.3.3. Threat of Substitutes

    • 3.3.4. Competitive Rivalry

    • 3.3.5. Bargaining Power among Buyers

  • 3.5. Market Dynamics

    • 3.5.1. Drivers

    • 3.5.2. Restraints

    • 3.5.3. Opportunities

• CHAPTER 4: FLOW DIVERSION ANEURYSM MARKET, BY PRODUCT

  • 4.1. Market Overview

    • 4.1.1 Market Size and Forecast, By Product

  • 4.2. Intrasaccular Flow Disruption Devices

    • 4.2.1. Key Market Trends, Growth Factors and Opportunities

    • 4.2.2. Market Size and Forecast, By Region

    • 4.2.3. Market Share Analysis, By Country

  • 4.3. FDS

    • 4.3.1. Key Market Trends, Growth Factors and Opportunities

    • 4.3.2. Market Size and Forecast, By Region

    • 4.3.3. Market Share Analysis, By Country

• CHAPTER 5: FLOW DIVERSION ANEURYSM MARKET, BY REGION

  • 5.1. Market Overview

    • 5.1.1 Market Size and Forecast, By Region

  • 5.2. North America

    • 5.2.1. Key Market Trends and Opportunities

    • 5.2.2. Market Size and Forecast, By Product

    • 5.2.3. Market Size and Forecast, By Country

    • 5.2.4. U.S. Flow Diversion Aneurysm Market

      • 5.2.4.1. Market Size and Forecast, By Product

    • 5.2.5. Canada Flow Diversion Aneurysm Market

      • 5.2.5.1. Market Size and Forecast, By Product

    • 5.2.6. Mexico Flow Diversion Aneurysm Market

      • 5.2.6.1. Market Size and Forecast, By Product

  • 5.3. Europe

    • 5.3.1. Key Market Trends and Opportunities

    • 5.3.2. Market Size and Forecast, By Product

    • 5.3.3. Market Size and Forecast, By Country

    • 5.3.4. France Flow Diversion Aneurysm Market

      • 5.3.4.1. Market Size and Forecast, By Product

    • 5.3.5. Germany Flow Diversion Aneurysm Market

      • 5.3.5.1. Market Size and Forecast, By Product

    • 5.3.6. Italy Flow Diversion Aneurysm Market

      • 5.3.6.1. Market Size and Forecast, By Product

    • 5.3.7. Spain Flow Diversion Aneurysm Market

      • 5.3.7.1. Market Size and Forecast, By Product

    • 5.3.8. UK Flow Diversion Aneurysm Market

      • 5.3.8.1. Market Size and Forecast, By Product

    • 5.3.9. Russia Flow Diversion Aneurysm Market

      • 5.3.9.1. Market Size and Forecast, By Product

    • 5.3.10. Rest Of Europe Flow Diversion Aneurysm Market

      • 5.3.10.1. Market Size and Forecast, By Product

  • 5.4. Asia-Pacific

    • 5.4.1. Key Market Trends and Opportunities

    • 5.4.2. Market Size and Forecast, By Product

    • 5.4.3. Market Size and Forecast, By Country

    • 5.4.4. China Flow Diversion Aneurysm Market

      • 5.4.4.1. Market Size and Forecast, By Product

    • 5.4.5. Japan Flow Diversion Aneurysm Market

      • 5.4.5.1. Market Size and Forecast, By Product

    • 5.4.6. India Flow Diversion Aneurysm Market

      • 5.4.6.1. Market Size and Forecast, By Product

    • 5.4.7. South Korea Flow Diversion Aneurysm Market

      • 5.4.7.1. Market Size and Forecast, By Product

    • 5.4.8. Australia Flow Diversion Aneurysm Market

      • 5.4.8.1. Market Size and Forecast, By Product

    • 5.4.9. Thailand Flow Diversion Aneurysm Market

      • 5.4.9.1. Market Size and Forecast, By Product

    • 5.4.10. Malaysia Flow Diversion Aneurysm Market

      • 5.4.10.1. Market Size and Forecast, By Product

    • 5.4.11. Indonesia Flow Diversion Aneurysm Market

      • 5.4.11.1. Market Size and Forecast, By Product

    • 5.4.12. Rest of Asia Pacific Flow Diversion Aneurysm Market

      • 5.4.12.1. Market Size and Forecast, By Product

  • 5.5. LAMEA

    • 5.5.1. Key Market Trends and Opportunities

    • 5.5.2. Market Size and Forecast, By Product

    • 5.5.3. Market Size and Forecast, By Country

    • 5.5.4. Brazil Flow Diversion Aneurysm Market

      • 5.5.4.1. Market Size and Forecast, By Product

    • 5.5.5. South Africa Flow Diversion Aneurysm Market

      • 5.5.5.1. Market Size and Forecast, By Product

    • 5.5.6. Saudi Arabia Flow Diversion Aneurysm Market

      • 5.5.6.1. Market Size and Forecast, By Product

    • 5.5.7. UAE Flow Diversion Aneurysm Market

      • 5.5.7.1. Market Size and Forecast, By Product

    • 5.5.8. Argentina Flow Diversion Aneurysm Market

      • 5.5.8.1. Market Size and Forecast, By Product

    • 5.5.9. Rest of LAMEA Flow Diversion Aneurysm Market

      • 5.5.9.1. Market Size and Forecast, By Product

• CHAPTER 6: COMPETITIVE LANDSCAPE

  • 6.1. Introduction

  • 6.2. Top Winning Strategies

  • 6.3. Product Mapping Of Top 10 Player

  • 6.4. Competitive Dashboard

  • 6.5. Competitive Heatmap

  • 6.6. Top Player Positioning, 2024

• CHAPTER 7: COMPANY PROFILES

  • 7.1. Balt Extrusion

    • 7.1.1. Company Overview

    • 7.1.2. Key Executives

    • 7.1.3. Company Snapshot

    • 7.1.4. Operating Business Segments

    • 7.1.5. Product Portfolio

    • 7.1.6. Business Performance

    • 7.1.7. Key Strategic Moves and Developments

  • 7.2. Medtronic Plc

    • 7.2.1. Company Overview

    • 7.2.2. Key Executives

    • 7.2.3. Company Snapshot

    • 7.2.4. Operating Business Segments

    • 7.2.5. Product Portfolio

    • 7.2.6. Business Performance

    • 7.2.7. Key Strategic Moves and Developments

  • 7.3. Stryker Corporation

    • 7.3.1. Company Overview

    • 7.3.2. Key Executives

    • 7.3.3. Company Snapshot

    • 7.3.4. Operating Business Segments

    • 7.3.5. Product Portfolio

    • 7.3.6. Business Performance

    • 7.3.7. Key Strategic Moves and Developments

  • 7.4. Acandis GmbH

    • 7.4.1. Company Overview

    • 7.4.2. Key Executives

    • 7.4.3. Company Snapshot

    • 7.4.4. Operating Business Segments

    • 7.4.5. Product Portfolio

    • 7.4.6. Business Performance

    • 7.4.7. Key Strategic Moves and Developments

  • 7.5. InspireMD

    • 7.5.1. Company Overview

    • 7.5.2. Key Executives

    • 7.5.3. Company Snapshot

    • 7.5.4. Operating Business Segments

    • 7.5.5. Product Portfolio

    • 7.5.6. Business Performance

    • 7.5.7. Key Strategic Moves and Developments

  • 7.6. Phenox GmbH

    • 7.6.1. Company Overview

    • 7.6.2. Key Executives

    • 7.6.3. Company Snapshot

    • 7.6.4. Operating Business Segments

    • 7.6.5. Product Portfolio

    • 7.6.6. Business Performance

    • 7.6.7. Key Strategic Moves and Developments

  • 7.7. MicroVention, Inc.

    • 7.7.1. Company Overview

    • 7.7.2. Key Executives

    • 7.7.3. Company Snapshot

    • 7.7.4. Operating Business Segments

    • 7.7.5. Product Portfolio

    • 7.7.6. Business Performance

    • 7.7.7. Key Strategic Moves and Developments

  • 7.8. Boston Scientific Corp.

    • 7.8.1. Company Overview

    • 7.8.2. Key Executives

    • 7.8.3. Company Snapshot

    • 7.8.4. Operating Business Segments

    • 7.8.5. Product Portfolio

    • 7.8.6. Business Performance

    • 7.8.7. Key Strategic Moves and Developments

  • 7.9. Cardinal Health Inc.

    • 7.9.1. Company Overview

    • 7.9.2. Key Executives

    • 7.9.3. Company Snapshot

    • 7.9.4. Operating Business Segments

    • 7.9.5. Product Portfolio

    • 7.9.6. Business Performance

    • 7.9.7. Key Strategic Moves and Developments

  • 7.10. Cook Group Inc.

    • 7.10.1. Company Overview

    • 7.10.2. Key Executives

    • 7.10.3. Company Snapshot

    • 7.10.4. Operating Business Segments

    • 7.10.5. Product Portfolio

    • 7.10.6. Business Performance

    • 7.10.7. Key Strategic Moves and Developments

• LIST OF TABLES

• TABLE 1. GLOBAL FLOW DIVERSION ANEURYSM MARKET, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 2. GLOBAL FLOW DIVERSION ANEURYSM MARKET FOR INTRASACCULAR FLOW DISRUPTION DEVICES, BY REGION, 2025-2033 ($MILLION)
• TABLE 3. GLOBAL FLOW DIVERSION ANEURYSM MARKET FOR FDS, BY REGION, 2025-2033 ($MILLION)
• TABLE 4. GLOBAL FLOW DIVERSION ANEURYSM MARKET, BY REGION, 2025-2033 ($MILLION)
• TABLE 5. NORTH AMERICA FLOW DIVERSION ANEURYSM, BY REGION, 2025-2033 ($MILLION)
• TABLE 6. NORTH AMERICA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 7. U.S. FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 8. CANADA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 9. MEXICO FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 10. EUROPE FLOW DIVERSION ANEURYSM, BY REGION, 2025-2033 ($MILLION)
• TABLE 11. EUROPE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 12. FRANCE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 13. GERMANY FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 14. ITALY FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 15. SPAIN FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 16. UK FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 17. RUSSIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 18. REST OF EUROPE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 19. ASIA-PACIFIC FLOW DIVERSION ANEURYSM, BY REGION, 2025-2033 ($MILLION)
• TABLE 20. ASIA-PACIFIC FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 21. CHINA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 22. JAPAN FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 23. INDIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 24. SOUTH KOREA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 25. AUSTRALIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 26. THAILAND FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 27. MALAYSIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 28. INDONESIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 29. REST OF ASIA PACIFIC FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 30. LAMEA FLOW DIVERSION ANEURYSM, BY REGION, 2025-2033 ($MILLION)
• TABLE 31. LAMEA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 32. BRAZIL FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 33. SOUTH AFRICA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 34. SAUDI ARABIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 35. UAE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 36. ARGENTINA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 37. REST OF LAMEA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2025-2033 ($MILLION)
• TABLE 38. BALT EXTRUSION: KEY EXECUTIVES
• TABLE 39. BALT EXTRUSION: COMPANY SNAPSHOT
• TABLE 40. BALT EXTRUSION: OPERATING SEGMENTS
• TABLE 41. BALT EXTRUSION: PRODUCT PORTFOLIO
• TABLE 42. BALT EXTRUSION: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 43. MEDTRONIC PLC: KEY EXECUTIVES
• TABLE 44. MEDTRONIC PLC: COMPANY SNAPSHOT
• TABLE 45. MEDTRONIC PLC: OPERATING SEGMENTS
• TABLE 46. MEDTRONIC PLC: PRODUCT PORTFOLIO
• TABLE 47. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 48. STRYKER CORPORATION: KEY EXECUTIVES
• TABLE 49. STRYKER CORPORATION: COMPANY SNAPSHOT
• TABLE 50. STRYKER CORPORATION: OPERATING SEGMENTS
• TABLE 51. STRYKER CORPORATION: PRODUCT PORTFOLIO
• TABLE 52. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 53. ACANDIS GMBH: KEY EXECUTIVES
• TABLE 54. ACANDIS GMBH: COMPANY SNAPSHOT
• TABLE 55. ACANDIS GMBH: OPERATING SEGMENTS
• TABLE 56. ACANDIS GMBH: PRODUCT PORTFOLIO
• TABLE 57. ACANDIS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 58. INSPIREMD: KEY EXECUTIVES
• TABLE 59. INSPIREMD: COMPANY SNAPSHOT
• TABLE 60. INSPIREMD: OPERATING SEGMENTS
• TABLE 61. INSPIREMD: PRODUCT PORTFOLIO
• TABLE 62. INSPIREMD: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 63. PHENOX GMBH: KEY EXECUTIVES
• TABLE 64. PHENOX GMBH: COMPANY SNAPSHOT
• TABLE 65. PHENOX GMBH: OPERATING SEGMENTS
• TABLE 66. PHENOX GMBH: PRODUCT PORTFOLIO
• TABLE 67. PHENOX GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 68. MICROVENTION, INC.: KEY EXECUTIVES
• TABLE 69. MICROVENTION, INC.: COMPANY SNAPSHOT
• TABLE 70. MICROVENTION, INC.: OPERATING SEGMENTS
• TABLE 71. MICROVENTION, INC.: PRODUCT PORTFOLIO
• TABLE 72. MICROVENTION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 73. BOSTON SCIENTIFIC CORP.: KEY EXECUTIVES
• TABLE 74. BOSTON SCIENTIFIC CORP.: COMPANY SNAPSHOT
• TABLE 75. BOSTON SCIENTIFIC CORP.: OPERATING SEGMENTS
• TABLE 76. BOSTON SCIENTIFIC CORP.: PRODUCT PORTFOLIO
• TABLE 77. BOSTON SCIENTIFIC CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 78. CARDINAL HEALTH INC.: KEY EXECUTIVES
• TABLE 79. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
• TABLE 80. CARDINAL HEALTH INC.: OPERATING SEGMENTS
• TABLE 81. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
• TABLE 82. CARDINAL HEALTH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 83. COOK GROUP INC.: KEY EXECUTIVES
• TABLE 84. COOK GROUP INC.: COMPANY SNAPSHOT
• TABLE 85. COOK GROUP INC.: OPERATING SEGMENTS
• TABLE 86. COOK GROUP INC.: PRODUCT PORTFOLIO
• TABLE 87. COOK GROUP INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

• LIST OF FIGURES

• FIGURE 1. GLOBAL FLOW DIVERSION ANEURYSM MARKET SEGMENTATION
• FIGURE 2. GLOBAL FLOW DIVERSION ANEURYSM MARKET
• FIGURE 3. SEGMENTATION FLOW DIVERSION ANEURYSM MARKET
• FIGURE 4. TOP INVESTMENT POCKET IN FLOW DIVERSION ANEURYSM MARKET
• FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
• FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
• FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
• FIGURE 8. LOW THREAT OF SUBSTITUTION
• FIGURE 9. HIGH COMPETITIVE RIVALRY
• FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALFLOW DIVERSION ANEURYSM MARKET
• FIGURE 11. FLOW DIVERSION ANEURYSM MARKET SEGMENTATION, BY BY PRODUCT
• FIGURE 12. FLOW DIVERSION ANEURYSM MARKET FOR INTRASACCULAR FLOW DISRUPTION DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
• FIGURE 13. FLOW DIVERSION ANEURYSM MARKET FOR FDS, BY COUNTRY, 2025-2033 ($MILLION)
• FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
• FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
• FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
• FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 18. COMPETITIVE DASHBOARD
• FIGURE 19. COMPETITIVE HEATMAP: FLOW DIVERSION ANEURYSM MARKET
• FIGURE 20. TOP PLAYER POSITIONING, 2024
• FIGURE 21. BALT EXTRUSION: NET SALES, 2022-2024 ($MILLION)
• FIGURE 22. BALT EXTRUSION: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 23. BALT EXTRUSION: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 24. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
• FIGURE 25. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 26. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 27. STRYKER CORPORATION: NET SALES, 2022-2024 ($MILLION)
• FIGURE 28. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 29. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 30. ACANDIS GMBH: NET SALES, 2022-2024 ($MILLION)
• FIGURE 31. ACANDIS GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 32. ACANDIS GMBH: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 33. INSPIREMD: NET SALES, 2022-2024 ($MILLION)
• FIGURE 34. INSPIREMD: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 35. INSPIREMD: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 36. PHENOX GMBH: NET SALES, 2022-2024 ($MILLION)
• FIGURE 37. PHENOX GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 38. PHENOX GMBH: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 39. MICROVENTION, INC.: NET SALES, 2022-2024 ($MILLION)
• FIGURE 40. MICROVENTION, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 41. MICROVENTION, INC.: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 42. BOSTON SCIENTIFIC CORP.: NET SALES, 2022-2024 ($MILLION)
• FIGURE 43. BOSTON SCIENTIFIC CORP.: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 44. BOSTON SCIENTIFIC CORP.: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 45. CARDINAL HEALTH INC.: NET SALES, 2022-2024 ($MILLION)
• FIGURE 46. CARDINAL HEALTH INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 47. CARDINAL HEALTH INC.: REVENUE SHARE, BY REGION, 2024 (%)
• FIGURE 48. COOK GROUP INC.: NET SALES, 2022-2024 ($MILLION)
• FIGURE 49. COOK GROUP INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
• FIGURE 50. COOK GROUP INC.: REVENUE SHARE, BY REGION, 2024 (%)